Update on Central Serous Chorioretinopathy
January 2016
in “
e-Oftalmo CBO Revista Digital de Oftalmologia
”
TLDR CSC is linked to mineralocorticoid receptor damage, stress, and steroid use, with treatments including drugs and laser therapies to prevent eye damage.
The document reviewed central serous chorioretinopathy (CSC), a condition involving the detachment of the neurosensory retina due to fluid accumulation. It was associated with mineralocorticoid receptor damage, psychological factors, and glucocorticoid use. Treatments included mineralocorticoid antagonists, rifampicin, finasteride, and local therapies like photocoagulation and laser treatments. Diagnostic imaging techniques such as fluorescein angiography and optical coherence tomography (OCT) were crucial for understanding and diagnosing CSC. The study concluded that managing CSC was challenging due to its recurrent and chronic nature, and treatment strategies needed to be individualized based on imaging analyses to effectively manage acute, chronic, and recurrent forms of CSC.